Tue, Mar 3, 2015, 2:38 PM EST - U.S. Markets close in 1 hr 22 mins

Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • dwinn2001 dwinn2001 Jan 21, 2013 8:53 AM Flag

    Typical FDA

    As always, getting better drugs or devices to sick people quickly is a low priority with the FDA. Yes, Rytary is a better drug and while you say you would make it at the Hayward plant, we aren't going to approve in case you make it at the Hayward plant.

    I bought shares in IPXL due to their financials and Rytary was just a plus. Even without Rytary, this is a very solid company and stock but this FDA decision is a little frustrating.

    Not sure what the FDA is trying to accomplish here.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
39.91-0.54(-1.33%)2:37 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.